Improvement after a supplement is not the same as a comparative result
Start with the comparison. A before-and-after change alone cannot isolate the contribution of an ingredient.
Coenzyme Q10
Selected research topic
Cardiovascular events
Human comparison studies did not find a clear difference in some measured outcomes.
Some findings concern patients or people with a deficiency.
- Publications for this topic
- 3
- Human comparison publications
- 1
- Publications needing review
- 1
Findings in the studies
LV diastolic function
- No clear difference from the comparison group was found.Patient group · Single ingredient · 30 days
Measurement and study conditions
- Study type
- Randomized controlled trial: subjects were randomly assigned to groups for comparison.
- Study population
- Human participants · Patient group
- Ingredients tested
- Single ingredient
- How results were compared
- Results were compared between groups. · Study comparison: CoQ10 plus routine treatment versus no CoQ10 plus routine treatment
- Additional measurement information
- Primary outcome
- Measurement time
- 30 days
functional capacity
Research with unclear study subject or type
- A change was reported, but the comparison could not be confirmed.Single ingredient · Varied across included studies
Measurement and study conditions
- Study type
- Systematic review
- Study population
- Recorded population category: Patient group. Whether the research involved humans needs confirmation.
- Ingredients tested
- Single ingredient
- How results were compared
- Study comparison: Review-level findings in patients with heart failure; direct comparator not specified in the abstrac
- Additional measurement information
- Primary outcome
- Measurement time
- Varied across included studies
major adverse cardiovascular events
Research with unclear study subject or type
- A change was reported, but the comparison could not be confirmed.Single ingredient · Varied across included studies
Measurement and study conditions
- Study type
- Systematic review
- Study population
- Recorded population category: Patient group. Whether the research involved humans needs confirmation.
- Ingredients tested
- Single ingredient
- How results were compared
- Study comparison: Review-level findings in patients with heart failure; direct comparator not specified in the abstrac
- Additional measurement information
- Primary outcome
- Measurement time
- Varied across included studies
This result is held for interpretation. That does not mean research found no effect.
Outcome groups needing additional review (1)
- cardiovascular death · Distinct papers needing additional review: 1Evidence criteria check: 1
One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.
Representative outcome and study details
Studies with an unspecified organism reported a change with no confirmed comparison group in functional capacity.
Single-ingredient studies · Includes patient groups · comparator not confirmed
1 publications linked to this result
- Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
Data coverage and detailed study classifications
Paper counts are separated by research topic below. One paper may contribute to multiple findings.
Analysis status: Public-ready
Ingredient analysis date:
How the grade was determined: B
The 54.4 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The B tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.
The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.
Papers linked to this ingredient overall: 113
Papers linked to this topic 3 · distinct papers 3 · papers with a confirmed human comparison 1 · papers needing additional review 1
A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.
- cardiovascular death: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- functional capacity: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- LV diastolic function: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
- major adverse cardiovascular events: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
What the research found
LV diastolic function
No clear difference in this measurement was found between the compared groups.
Controlled study in people · Single ingredient · Patient group
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
functional capacity
A change was reported, but the comparison could not be confirmed.
Review · Single ingredient · Patient group
Analysis coverage and paper counts
1 paper · 1 measured outcome
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
major adverse cardiovascular events
A change was reported, but the comparison could not be confirmed.
Review · Single ingredient · Patient group
Analysis coverage and paper counts
1 paper · 1 measured outcome
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
cardiovascular death
The study needs further checking before its result can be interpreted.
Review · Single ingredient · Patient group
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
How to read research findings
How should I read research findings?
Research guidesNo clear difference and an uninterpretable result are different
A reported null comparison contains a result. An abstract without an interpretable comparison leaves a question unresolved.
Paper counts and study counts are different
Count original research separately from research that reanalyzes it. Publication volume is neither replication nor a quality rating.
Side effects and combination findings
Findings from this ingredient alone are shown separately from those involving another supplement or medication.
No combination cautions are available to show in the current data. This does not guarantee safety.
Review 2 combination findings and 0 findings that outperformed an ingredient alone.
Reported improvements with combinations
Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.
Combinations with reported improvement
The combination showed improvement, but each ingredient's contribution is unclear.
CurcuminThe study suggests a possible synergistic effect of nano-curcumin and CoQ10 on clinical features of migraine compared to monotherapy or placebo.
SeleniumCombined supplementation with selenium and Coenzyme Q10 resulted in significantly improved renal function markers compared to placebo.